We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

3 top US dividend stocks for value investors to consider in 2024

I’m searching far and wide to find the best dividend stocks that money can buy. Do the Americans have more to offer when it comes to value investing?

| More on:
The flag of the United States of America flying in front of the Capitol building

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Having largely covered every valuable dividend stock in the UK market, I decided to see what’s happening across the pond. US stocks on average don’t appear to pay as high dividends as the UK, with a stronger focus on growth

However, I’ve uncovered three US stocks that could secure investors decent value via dividends in 2024.

Should you buy AbbVie shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

AbbVie

AbbVie (NYSE:ABBV) is a pharmaceutical giant in the US and the largest company on this list with a $292bn market cap. In addition to being a good dividend payer, it’s a powerful growth stock, up 110% in the past five years.

Its growth could be affected from that one thing that always threatens pharma firms – patents expiring. The patent for AbbVie’s top-selling product, Humira, expired last year, allowing a flood of biosimilar products into the US. It also faces strong competition from Johnson & Johnson and Procter & Gamble, two larger US pharma giants with higher revenue.

Still, AbbVie is doing well enough to pay a decent 3.8% dividend yield, despite earnings per share (EPS) at half the cost of its dividend per share ($2.72 compared to $6.20). Yet that hasn’t affected payments – they’ve been stable and consistent for the past 10 years, increasing from $0.42 to $1.55.

Verizon

Verizon (NYSE:VZ) is one of the largest telecom companies in the US, providing mobile, broadband and wireless services to retail and business clients. It’s the 47th largest company on the S&P 500, with a market cap of $167.8bn and a $39.91 share price. That’s higher than fellow telecom stalwarts AT&T and Comcast but lower than key competitor T-Mobile, which places 40th with a $191bn market cap. 

Verizon’s share price growth has been slow of late, with only a 3.1% gain in the past year. I believe the company is facing a saturated market and the high cost of implementing new 5G technology. 

Fortunately, it has a great 6.7% dividend yield, albeit with a slightly high payout ratio of 96%. That’s because its EPS and dividend per share are very close, at $2.76 and $2.66, respectively. Still, it’s got a solid track record of making payments, with a $0.67 dividend due on 1 May.

IBM

Arguably the world’s oldest computer company, IBM (NYSE:IBM) is still pushing boundaries despite stiff competition from newcomers in the tech industry. It’s the smallest of the three companies on this list, just below Verizon with a $166.4bn market cap.

Although it has a lasting reputation and strong market presence, IBM’s pivot towards AI and cloud computing has been costly. Debt has been rising while revenue has declined, threatening the firm’s profitability. With Microsoft and Amazon taking the lion’s share of this market, IBM may struggle to remain relevant. 

But for now, it’s a strong dividend payer in the US market. The 3.6% yield isn’t great but still better than the S&P 500 average of 1.35%. It currently pays out $6.64 per share, which is sufficiently covered by an EPS of $8.20. So it’s unlikely that the dividend will be cut any time soon.

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Mark Hartley has positions in Microsoft. The Motley Fool UK has recommended Amazon, International Business Machines, and Microsoft. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

See what £10,000 invested in dismal Diageo shares just 1 week ago is worth today

Diageo shares are all hangover and no fizz, says Harvey Jones. How long must investors wait before the FTSE 100…

Read more »

Rear view image depicting a senior man in his 70s sitting on a bench leading down to the iconic Seven Sisters cliffs on the coastline of East Sussex, UK. The man is wearing casual clothing - blue denim jeans, a red checked shirt, navy blue gilet. The man is having a rest from hiking and his hiking pole is leaning up against the bench.
Investing Articles

Up 1,146%! 7 things I’ve learned from the stunning Rolls-Royce share price comeback 

Harvey Jones has made a fair bit of money out of the booming Rolls-Royce share price, but he's also learned…

Read more »

Golden Retirees Heading to Beach
Investing Articles

4 steps to building a £38,456 retirement income with ISA shares

Investing £300 a month could deliver a life-changing cash stream in retirement with high-yield income shares. Royston Wild explains how.

Read more »

Content white businesswoman being congratulated by colleagues at her retirement party
Investing Articles

How investing in a Cash ISA could cost you a comfortable retirement

Cash ISAs are celebrated for the brilliant tax benefits they provide. But could focusing on them cost savers the chance…

Read more »

Young black woman in a wheelchair working online from home
Investing Articles

How much could Barclays shares pay in dividends by 2028?

Barclays is one of the FTSE 100's most popular dividend shares. How much could they provide over the next three…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

With a 6% yield and a P/E of just 7.4, is this share a screaming buy for a second income?

Mark Hartley looks at the second income potential of a popular UK dividend stock that still looks undervalued despite compelling…

Read more »

Investing Articles

Forget Nvidia! This ETF is booming inside my Stocks and Shares ISA

A thematic ETF inside this writer's ISA has more doubled the return of Nvidia stock so far in 2026. But…

Read more »

Shot of an young mixed-race woman using her cellphone while out cycling through the city
Investing Articles

These cheap FTSE 250 shares could deliver a £1,550 ISA income in just 12 months!

Searching for the best low-cost dividend stocks to buy? Royston Wild reveals two FTSE 250 property shares with yields above…

Read more »